BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21520044)

  • 21. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.
    Scuto A; Krejci P; Popplewell L; Wu J; Wang Y; Kujawski M; Kowolik C; Xin H; Chen L; Wang Y; Kretzner L; Yu H; Wilcox WR; Yen Y; Forman S; Jove R
    Leukemia; 2011 Mar; 25(3):538-50. PubMed ID: 21164517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
    Bhardwaj A; Sethi G; Vadhan-Raj S; Bueso-Ramos C; Takada Y; Gaur U; Nair AS; Shishodia S; Aggarwal BB
    Blood; 2007 Mar; 109(6):2293-302. PubMed ID: 17164350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
    Fang P; Hwa V; Rosenfeld RG
    Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
    Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
    PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
    Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
    BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis.
    Yang F; Jove V; Buettner R; Xin H; Wu J; Wang Y; Nam S; Xu Y; Ara T; DeClerck YA; Seeger R; Yu H; Jove R
    Cancer Biol Ther; 2012 May; 13(7):534-41. PubMed ID: 22406995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
    Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
    Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma.
    Liang P; Cheng SH; Cheng CK; Lau KM; Lin SY; Chow EY; Chan NP; Ip RK; Wong RS; Ng MH
    Haematologica; 2013 Feb; 98(2):288-95. PubMed ID: 22929979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arctiin is a pharmacological inhibitor of STAT3 phosphorylation at tyrosine 705 residue and potentiates bortezomib-induced apoptotic and anti-angiogenic effects in human multiple myeloma cells.
    Lee JH; Kim C; Lee J; Um JY; Sethi G; Ahn KS
    Phytomedicine; 2019 Mar; 55():282-292. PubMed ID: 30668440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support.
    Li J; Favata M; Kelley JA; Caulder E; Thomas B; Wen X; Sparks RB; Arvanitis A; Rogers JD; Combs AP; Vaddi K; Solomon KA; Scherle PA; Newton R; Fridman JS
    Neoplasia; 2010 Jan; 12(1):28-38. PubMed ID: 20072651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.
    Dimberg LY; Dimberg A; Ivarsson K; Fryknäs M; Rickardson L; Tobin G; Ekman S; Larsson R; Gullberg U; Nilsson K; Öberg F; Wiklund HJ
    BMC Cancer; 2012 Jul; 12():318. PubMed ID: 22838736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells.
    Liu S; Ma Z; Cai H; Li Q; Rong W; Kawano M
    Eur J Haematol; 2010 Feb; 84(2):137-44. PubMed ID: 19878271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties.
    Uchihara Y; Ohe T; Mashino T; Kidokoro T; Tago K; Tamura H; Funakoshi-Tago M
    Pharmacol Rep; 2019 Dec; 71(6):1067-1078. PubMed ID: 31627175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
    Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
    Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells.
    Liu Y; Fuchs J; Li C; Lin J
    Cell Cycle; 2010 Sep; 9(17):3423-7. PubMed ID: 20818158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells.
    Monaghan KA; Khong T; Burns CJ; Spencer A
    Leukemia; 2011 Dec; 25(12):1891-9. PubMed ID: 21788946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
    Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
    Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases.
    Lee JH; Chiang SY; Nam D; Chung WS; Lee J; Na YS; Sethi G; Ahn KS
    Cancer Lett; 2014 Apr; 345(1):140-8. PubMed ID: 24333736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
    Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
    Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.